RYSE Asset Management
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Healthcare, HealthTech, Digital Health, Medical Devices, Biotechnology
Stage Focus
Seed, Series A
Geographical Focus
United States, United Kingdom, Canada, Germany, Hong Kong, Japan, Australia, Singapore, China, India, Brazil, France, Denmark, Switzerland, South Korea, Netherlands, New Zealand, Sweden, Norway, Finland
Industries Focus
- Healthcare
- HealthTech
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Medtech
- Biotechnology
- Women's Health
- Wellness
- Fitness
- Nutrition
- E-health
- Mental Health
- Telemedicine
Investment Size:
1,000,000 to 10,000,000 USD
Investor Details Founded: 2017
RYSE Asset Management is a London-based venture capital firm founded in 2017, focusing on early-stage healthcare investments. The firm aims to reimagine healthcare by supporting innovative HealthTech companies that address unmet clinical needs and improve access to affordable care. By partnering with visionary founders, RYSE seeks to drive transformative change in the healthcare sector.
The firm's investment strategy centers on identifying and scaling early-stage companies in sectors such as digital diagnostics, digital therapeutics, medical devices, and data platforms. RYSE collaborates with industry leaders like DigitalHealth.London, the NHS, Novartis, and Medtronic to bridge the gap between innovative ideas and real-world impact. This approach enables the firm to empower bold founders globally, typically investing in Seed and Series A HealthTech companies.
RYSE's portfolio includes companies that tackle global healthcare challenges, including an aging population, chronic diseases, and the demand for more efficient care delivery. The firm's expertise spans areas such as cardiovascular health, metabolic disorders, oncology, mental health, women's health, and health AI. Through strategic partnerships and a commitment to innovation, RYSE is dedicated to transforming the future of healthcare and improving lives worldwide.
Requirements
- Innovative HealthTech solutions
- Addressing unmet clinical needs
- Early-stage companies (Seed and Series A)
- Global scalability potential
- Alignment with RYSE's mission to transform healthcare
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
Portfolio Companies
- Huma
- Babylon Health
- Medopad
- Liva Healthcare
- CureMetrix
- Kheiron Medical
- Qventus
Mentioned In
-
$24.95
-
$24.95
-
$19.95
-
$49.95
-
$9.95
-
$19.95
-
$39.95
-
$19.95
-
$99.00
-
$245.00
Claim this Investor
Are you an official representative of RYSE Asset Management?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim